CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.565
-0.002 (-0.35%)
At close: Feb 27, 2026, 4:00 PM EST
0.554
-0.011 (-2.00%)
After-hours: Feb 27, 2026, 7:10 PM EST
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$43,421
Profits / Employee
-$213,333
Market Cap
8.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Aptevo Therapeutics | 37 |
| Theriva Biologics | 22 |
| Moleculin Biotech | 17 |
| CalciMedica | 15 |
| Kiora Pharmaceuticals | 12 |
| Alzamend Neuro | 7 |
| Ernexa Therapeutics | 6 |
CLGN News
- 2 days ago - CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler - PRNewsWire
- 5 days ago - CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex - PRNewsWire
- 11 days ago - CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - PRNewsWire
- 23 days ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS - PRNewsWire
- 4 months ago - CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada - PRNewsWire
- 4 months ago - CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology - PRNewsWire